Delivery Order SPE2DB24D2212-SPE2DB24FHNTD

Award Date 9/24/24
Potential Completion Date 9/25/24
Potential Value $1.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order with a firm fixed price of $1,425.06 for the procurement of Procainamide 1 gram/10 ml vials. The contract has a period of performance through May 21, 2025 and does not include a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,717.78 delivery order contract is for the supply of 4566997370 - Procainamide 1 Gram/10 ML Vial 10ML. The contract has a firm fixed price pricing type and an ultimate completion date of January 22, 2025. Amerisourcebergen Drug Corp is the prime contractor, and the contract is not designated as a...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $3,140.57, is for the supply of 4561655760 - Procainamide 1 gram/10 ml vial, 10 ml. The contract has an ultimate completion date of August 1, 2023 and was awarded on July 31, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation's Corporate Office division. The $2,532.81 firm fixed-price delivery order is for the supply of 4,565,708,508 units of Procainamide 1 gram/10 ml vial, with a performance period ending on September 9, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025, which enables the DLA to...
This is a $3,079.84 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of PROCAINAMIDE 1 GRAM/10 ML VIAL 10ML, a medical supply, with a period of performance through July 9, 2025. The contract is not set aside and represents open competition. Amerisourcebergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Procainamide 1 gram/10 ml vials, a medication used in the treatment of certain heart rhythm disorders. The contract has a ceiling value of $6,660.76 and a period of performance through January 7, 2025. The contract is a firm fixed-price delivery order and does...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,209.72, is for the procurement of 4566753882 ! PROCAINAMIDE 1 GRAM/10 ML VIAL 10ML. The contract is a firm fixed-price delivery order with an ultimate completion date of December 19, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with a ceiling value of $9,772.23, is for the delivery of 4,567,799,540 units of Procainamide 1,000 mg/2 ml vials, a medication used to treat certain heart rhythm disorders. The contract has a firm fixed price pricing type and an ultimate completion date of April 7, 2025. The contract was awarded on...
This is a federal delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $5,960.23, is for the supply of PROCAINAMIDE 1 GRAM/10 ML VIAL 10ML, a medical product. The contract is a firm fixed-price delivery order, with an ultimate completion date of July 7, 2025. Amerisourcebergen Drug Corp is the prime contractor, and the contract is not designated as a set-aside. This...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to supply 4,568,433,683 units of Procainamide 1 Gram/10 ML Vial 10ML. The contract has a ceiling value of $2,850.12 and a completion date of June 4, 2025. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by AmerisourceBergen Drug Corp with the DLA Troop Support Medical, which provides...
  • SPE2DB24D2212
    Indefinite Delivery Contract
  • SPE2DB24D2212-SPE2DB24FHNTD
    Delivery Order

The Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp for the supply of Procainamide 1 gram/10 mL vials. The $1,741.15 firm-fixed-price contract has a completion date of September 25, 2024. Amerisourcebergen, a major pharmaceutical distributor, is providing these essential medical commodities through an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999 through December 2025. This contract does not utilize a set-aside designation.

Generated 12/24/24, 9:12 AM